Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Dual GLP-1/GIP receptor agonists, such as tirzepatide, simultaneously activate both receptors, thereby potentiating glycemic control, promoting weight loss, and ameliorating metabolic dysfunction
Perfect macros that ignore real life usually fail
Average weight loss in clinical trials is approximately 5-6% of body weight
Highly recommend Dr
2-8C after reconstitution, protected from light Use: Laboratory research only not for human or animal consumption This is a patented investigational compound sold for laboratory research only
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
